Clinical Trials Browser

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT03065062 2026-02-13

Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors

Phase 1 Suspended

75 enrolled

GastrointestinalGynecologicHead & Neck

Head and Neck Neoplasms, Neoplasms, Pancreatic Neoplasms, Endometrial Neoplasms

NCT06666218 2026-01-14

Helping Ovarian Cancer Patients Cope With Their Illness (HOPE)

Phase NA Suspended

60 enrolled

Gynecologic

Ovarian Neoplasms

NCT05866679 2025-10-14

Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging

Phase 1 Suspended

30 enrolled

Gynecologic

Ovarian Neoplasms

NCT05337735 2025-10-09

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

Phase 2 Suspended

140 enrolled

EndocrineGynecologicLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Hodgkin Disease, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT03275298 2025-04-23

ESME OC

Suspended

13,331 enrolled

Gynecologic

Ovarian Neoplasms

NCT05506800 2023-02-23

Guangzhou Women's Health Cohort Study (GWHCS)

Suspended

1,000,000 enrolled

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Diabetes Mellitus, Hypertension, Lung Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT03945786 2021-12-06